The AI in Business Podcast Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen
9 snips
Apr 7, 2026 Emma Vitalini, Head of Global Digital Health Technology Innovation at Amgen, applies digital health, interoperability, and AI to speed clinical research. She discusses surfacing genomic and unstructured data for patient identification. She covers decentralized trial tools like at-home sampling and wearables. She explains API-based data queries and modular consent to scale globally while keeping compliance and trust intact.
AI Snips
Chapters
Transcript
Episode notes
AI Surfaces Hidden Genomic Signals
- AI can surface unstructured genomic and clinical data to identify precise patient subgroups for trials.
- Emma Vitalini explains genomic results often live in provider note fields and AI speeds consistent surfacing across site records.
Decentralization Unlocks Global Representation
- Decentralized trial tech plus AI enables global, representative recruitment by removing location barriers.
- Emma notes at-home sampling kits, validated wearables, and voice assistants can extend screening and monitoring remotely.
Social Media Funnels Needed Huge Scale
- Emma describes experiments like using social media funnels to find patients but notes conversion requires huge scale.
- She contrasts that with empowering patients to self-nominate via Apple Health data sharing and IoT signals.